Rivastigmine is a cholinesterase enzyme inhibitor, which acts on butyl cholinesterase and acetyl cholinesterase. It is a cholinergic agent that aids in the treatment of Alzheimer’s and Parkinson’s disease. The drug can be administered orally or in transdermal patched form, owing to its small molecular size.
Increasing geriatric population is a major driver for growth of the Rivastigmine Market. According to The Alzheimer Association, in 2018, the risk of suffering from dementia can increase double fold above the age of 65 years in every 5 years. Moreover, increasing prevalence of cardiovascular diseases worldwide also accounts for the development of Alzheimer’s disease, thereby boosting demand for rivastigmine.
Leading Companies in the Rivastigmine Industry:
1) Novartis AG
Novartis AG is a Swiss pharmaceutical corporation founded in March 1996 by Johann Rudolf The headquarters are located in Basel Switzerland, Cambridge, The United States of America and Massachusetts. It is one of the largest Pharma based company incorporated. The drugs manufactured are sold worldwide. Total revenue earned as of 2022 is US 50.545 billion dollars.
In June, 2022 Novartis completed the acquisition of Kedalion Therapeutics and its AcuStream technology.
2) Apotex Inc.
Apotex Inc. is a pharmaceutical corporation based in Canada. Apotex is the largest producer of generic drugs in Canada. The company manufactures and sells generic medications for diseases like cancer, diabetes, high cholesterol and blood pressure. The company was founded in the year 1974 and the headquarters are located in Toronto, Ontario, Canada. The company was founded by Barry Sherman.
In July, 2022 Apotex Inc. announced the launch of APO-Apixaban tablets. Canada’s first generic alternative to Eliquis.
3) Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. (also known as Teva Pharmaceuticals) is an Israeli multinational pharmaceutical company Commission of autoimmune diseases, from the European. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals. Teva's facilities are located in Israel, North America, Europe, Australia, and South America. The company was founded in the year 1901, and the headquarters are located in Tel Aviv, Israel.
On 28 January 2020, the company announced that the Food and Drug Administration (FDA) had approved an autoinjector device for Ajovy (fremanezumab-vfrm) injection.
4) Dr. Reddy's Laboratories
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology. The company was founded in the year 1984, and the headquarters are located in Hyderabad, Telangana, India.
As of Februray 2022, the company has announced Agreement to Acquire Mayne Pharma’s U.S. Generic Prescription Product Portfolio.
5) Actavis Generics
Actavis Generics (formerly known as Watson Pharmaceuticals and Actavis plc. is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial presence across approximately 100 countries. The company was founded in the year 1984, and the headquarters are located in Dublin, Ireland.
